A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. (Q53236914)
Jump to navigation
Jump to search
scientific article published in September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. |
scientific article published in September 2011 |
Statements
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. (English)
1 reference
Thomas E Stinchcombe
1 reference
Amy H Peterman
1 reference
Carrie B Lee
1 reference
Dominic T Moore
1 reference
Jennifer L Beaumont
1 reference
Daniel S Bradford
1 reference
Kamal Bakri
1 reference
Mark Taylor
1 reference
Jeffrey M Crane
1 reference
Garry Schwartz
1 reference
Thomas A Hensing
1 reference
Edwin McElroy
1 reference
Harvey B Niell
1 reference
Harry D Harper
1 reference
Sridhar Pal
1 reference
Mark A Socinski
1 reference
1 September 2011
1 reference
6
1 reference
9
1 reference
1569-1577
1 reference
Identifiers
1 reference